Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence

NACompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Opiate Substitution Treatment
Interventions
BEHAVIORAL

Standard Medical Management (SMM)

SMM is designed to provide basic advice about opioid dependence and encouragement to adhere to treatment recommendations. Sessions provide support and monitoring of medication compliance, dose, withdrawal, adverse effects, and discussion of medical complications of opioid and other drug use. Early in treatment, the focus will be on helping patients adjust to the medications (e.g., monitoring withdrawal or other adverse symptoms, tolerating discomfort, curtailing illicit drug use, and referral to self-help). As treatment progresses, the practitioner may focus more on educating the patient about the social and behavioral factors perpetuating addiction and encourage behavioral and lifestyle change to support recovery.

Trial Locations (1)

95821

Kaiser Sacramento Chemical Dependency Recovery Program, Sacramento

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Kaiser Permanente

OTHER

NCT02496403 - Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence | Biotech Hunter | Biotech Hunter